Learn why combining AI-enabled trial matching with transportation, lodging, and financial assistance is essential to turning ...
NEW YORK--(BUSINESS WIRE)--Massive Bio, a leading artificial intelligence (AI) analytics company specializing in precision oncology, has been selected by the Precision Cancer Consortium (PCC), a ...
Trial records are sourced from ClinicalTrials.gov and indexed using natural language processing techniques, including named entity recognition, term normalization, and relationship extraction.
WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, a leading provider of AI-driven, molecular and immune profiling solutions, today announced its participation in the Molecular Analysis for Combination ...
NCI-MATCH precision medicine trial makes major contributions to the use of tumor gene testing to select treatment for patients; new data has broad relevance in medicine and provides a roadmap for ...
AI and Invasive Assessment of Coronary Disease (OCT and Beyond) Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the ...
NSABP FC-11: A phase II study of neratinib (N) plus trastuzumab (T) or n plus cetuximab (C) in patients (pts) with "quadruple wild-type (WT)" (KRAS/NRAS/BRAF/PIK3CA WT) metastatic colorectal cancer ...
Dublin, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The "Precision Oncology Market Report 2025" report has been added to ResearchAndMarkets.com's offering. The precision oncology market size has grown rapidly ...
Precision medicine has revolutionized the landscape of neurological care, shifting from “one-size-fits-all” approaches to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback